Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Balloon angioplasty in acute and chronic coronary artery disease

Journal Article · · JAMA, Journal of the American Medical Association; (USA)
;  [1]
  1. Mayo Clinic and Mayo Foundation, Rochester, MN (USA)
Percutaneous transluminal coronary angioplasty has grown exponentially since its introduction. Currently, selection criteria include single-vessel and multivessel disease, stable and unstable angina, and acute infarction. The outcome depends on specific patient and antiographic characteristics. In ideal lesions, success rates should be greater than 90%, with low morbidity and mortality. With more severe and diffuse multivessel disease, success rates are lower and complication rates are higher. In these cases, percutaneous transluminal coronary angioplasty still offers a reasonable option, provided complete revascularization can be achieved or the angina-producing lesion dilated. Numerous issues remain unresolved, including (1) the role of percutaneous transluminal coronary angioplasty vs coronary surgery (currently being tested), (2) restenosis, which occurs in approximately 30% of treated lesions, and (3) organizational adjustments such as training and certification to maintain high standards of care.
OSTI ID:
5475152
Journal Information:
JAMA, Journal of the American Medical Association; (USA), Journal Name: JAMA, Journal of the American Medical Association; (USA) Vol. 261:14; ISSN 0098-7484; ISSN JAMAA
Country of Publication:
United States
Language:
English